Peritoneal carcinomatosis (PC) has experienced a remarkable transformation from being viewed as an untreatable terminal cancer stage to becoming a promising therapeutic target. This shift represents one of the most significant developments in oncology, driven by revolutionary surgical techniques, innovative chemotherapy protocols, and enhanced understanding of tumor mechanisms. The condition,...